日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Predicting venous thromboembolism risk from endogenous thrombin potential-based normalized activated protein C sensitivity ratio assay: toward early assessment of combined oral contraceptives

基于内源性凝血酶潜能的标准化活化蛋白C敏感性比率测定预测静脉血栓栓塞风险:迈向联合口服避孕药的早期评估

Morimont, Laure; Creinin, Mitchell D; Gaspard, Ulysse; Foidart, Jean-Michel; Douxfils, Jonathan

Body-identical estrogens in combined hormonal contraceptives: A safer path forward

复方激素避孕药中的人体同源雌激素:一条更安全的道路

Chabbert-Buffet, Nathalie; Diaz Yamal, Ivonne J; Douxfils, Jonathan; Foidart, Jean-Michel; Fruzzetti, Franca; Gemzell-Danielsson, Kristina; Nappi, Rossella E; Osuga, Yutaka; Descamps, Philippe

Critical Considerations in the Interpretation of Bone Turnover Marker Data in Hormonal Contraceptive Users. Comment on Tassi et al. Hormonal Contraception and Bone Metabolism: Emerging Evidence from a Systematic Review and Meta-Analysis of Studies on Post-Pubertal and Reproductive-Age Women. Pharmaceuticals 2025, 18, 61

对激素避孕药使用者骨转换标志物数据解读的关键考量。评述Tassi等人发表于《Pharmaceuticals》2025年第18卷第61页的文章“激素避孕与骨代谢:来自青春期后和育龄期女性研究的系统评价和荟萃分析的新证据”。

Douxfils, Jonathan; Foidart, Jean-Michel

Comparison of Estetrol Exposure between Women and Mice to Model Preclinical Experiments and Anticipate Human Treatment

比较女性和小鼠雌四醇暴露量,以模拟临床前实验并预测人类治疗

Gallez, Anne; Nys, Gwenaël; Wuidar, Vincent; Dias Da Silva, Isabelle; Taziaux, Mélanie; Kinet, Virginie; Tskitishvili, Ekaterine; Noel, Agnès; Foidart, Jean-Michel; Piel, Géraldine; Fillet, Marianne; Péqueux, Christel

A multicenter, randomized, placebo-controlled study to select the minimum effective dose of estetrol in postmenopausal participants (E4Relief): part 2-vaginal cytology, genitourinary syndrome of menopause, and health-related quality of life

一项多中心、随机、安慰剂对照研究,旨在确定绝经后女性雌四醇的最低有效剂量(E4Relief):第二部分——阴道细胞学、绝经期泌尿生殖系统综合征和健康相关生活质量

Gaspard, Ulysse; Taziaux, Mélanie; Jost, Maud; Coelingh Bennink, Herjan J T; Utian, Wulf H; Lobo, Rogerio A; Foidart, Jean-Michel

Estetrol Is Safe and Well Tolerated during Treatment of Hospitalized Men and Women with Moderate COVID-19 in a Randomized, Double-Blind Study

一项随机、双盲研究表明,在治疗中度 COVID-19 住院男性和女性患者期间,雌四醇安全且耐受性良好。

Foidart, Jean Michel; Simon, Krzysztof; Utian, Wulf H; Mauvais-Jarvis, Franck; Douxfils, Jonathan; Dixon, Graham; Barrington, Philip

Estetrol: From Preclinical to Clinical Pharmacology and Advances in the Understanding of the Molecular Mechanism of Action

雌四醇:从临床前到临床药理学以及对分子作用机制理解的进展

Gérard, Céline; Foidart, Jean-Michel

Response to paper by Binkowska et al. Risk of venous thromboembolism during the use of oral estrogen-progestogen hormone therapies in light of most recent research findings. Commentary: Oestradiol is not the holy grail in the quest for the ideal oestrogen therapy

对Binkowska等人论文的回应:鉴于最新研究结果,口服雌激素-孕激素激素疗法治疗期间发生静脉血栓栓塞的风险。评论:雌二醇并非寻求理想雌激素疗法的万能灵药。

Douxfils, Jonathan; Foidart, Jean-Michel; Gaspard, Ulysse; Chatel, Guillaume; Taziaux, Mélanie; Jost, Maud; Gérard, Céline; Morimont, Laure

The benefits of estetrol addition to drospirenone for contraception

雌二醇与屈螺酮联合用于避孕的益处

Foidart, Jean Michel; Gemzell-Danielsson, Kristina; Kubba, Ali; Douxfils, Jonathan; Creinin, Mitchell D; Gaspard, Ulysse

Low Thrombin Generation in Users of a Contraceptive Containing Estetrol and Drospirenone

使用含雌四醇和屈螺酮的避孕药者凝血酶生成减少

Morimont, Laure; Jost, Maud; Gaspard, Ulysse; Foidart, Jean-Michel; Dogné, Jean-Michel; Douxfils, Jonathan